Skip to content
MedsAcross

Manufacturer

Galderma Laboratories

Pharmaceutical manufacturer based in Switzerland
Switzerland
Products listed
9
Molecules
9
Therapy areas
3

Galderma Laboratories is a pharmaceutical manufacturer based in Switzerland. MedsAcross lists 9 of its products across 9 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
Switzerland
Indian manufacturer
No
Also listed as
Galderma Laboratories, L.P.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Galderma Laboratories products through licensed channels, with the documents your regulator needs.

Dermatology

5 presentations

Dermatology overview
MedicineActive ingredientRegisterAvailability
Aklief 50 mcg/g creamTopicalTrifaroteneUS FDAAvailable on request
Differin 0.3% gelTopicalAdapaleneUS FDAAvailable on request
Nemluvio 30 mg/100 mg powder for injectionSubcutaneous Cold chainNemolizumabUS FDAAvailable on request
Soolantra 1% creamTopicalIvermectinUS FDAAvailable on request
Vectical 3 mcg/g ointmentTopicalCalcitriolUS FDAAvailable on request

Ophthalmology

1 presentation

Ophthalmology overview
MedicineActive ingredientRegisterAvailability
Mirvaso 0.5% gelTopicalBrimonidineUS FDAAvailable on request

Antibiotics

1 presentation

Antibiotics overview
MedicineActive ingredientRegisterAvailability
Oracea 40 mg capsuleOralDoxycyclineUS FDAAvailable on request

Other products

2 presentations

MedicineActive ingredientRegisterAvailability
Dysport 300 units powder for injectionIntramuscular Cold chainBotulinum toxin type aUS FDAAvailable on request
Tri-luma 0.1 mg/40 mg/0.5 mg per g creamTopical Cold chainFluocinolone acetonide, Hydroquinone and TretinoinUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Galderma Laboratories

Send a request for any of these products. We confirm the licensed source, documents and lead time.